234 related articles for article (PubMed ID: 22508783)
1. Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer.
Huh JW; Lee JH; Kim HR
Arch Surg; 2012 Apr; 147(4):366-72. PubMed ID: 22508783
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing oncological outcomes in patients who develop pulmonary metastases after curative resection of colorectal cancer.
Kim CH; Huh JW; Kim HJ; Lim SW; Song SY; Kim HR; Na KJ; Kim YJ
Dis Colon Rectum; 2012 Apr; 55(4):459-64. PubMed ID: 22426271
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms.
Ruffini E; Asioli S; Filosso PL; Lyberis P; Bruna MC; Macrì L; Daniele L; Oliaro A
Ann Thorac Surg; 2009 Feb; 87(2):365-71; discussion 371-2. PubMed ID: 19161739
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer.
Horne ZD; Jack R; Gray ZT; Siegfried JM; Wilson DO; Yousem SA; Nason KS; Landreneau RJ; Luketich JD; Schuchert MJ
J Surg Res; 2011 Nov; 171(1):1-5. PubMed ID: 21571304
[TBL] [Abstract][Full Text] [Related]
5. Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.
Zlobec I; Baker K; Minoo P; Hayashi S; Terracciano L; Lugli A
Cancer; 2009 Sep; 115(17):4021-9. PubMed ID: 19517467
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer.
Lim SB; Yu CS; Jang SJ; Kim TW; Kim JH; Kim JC
Dis Colon Rectum; 2010 Apr; 53(4):377-84. PubMed ID: 20305435
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2010 Aug; 17(8):2066-72. PubMed ID: 20182809
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant?
Peeples C; Shellnut J; Wasvary H; Riggs T; Sacksner J
Dis Colon Rectum; 2010 Nov; 53(11):1517-23. PubMed ID: 20940600
[TBL] [Abstract][Full Text] [Related]
9. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
[TBL] [Abstract][Full Text] [Related]
10. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
[TBL] [Abstract][Full Text] [Related]
11. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.
Laghi L; Bianchi P; Miranda E; Balladore E; Pacetti V; Grizzi F; Allavena P; Torri V; Repici A; Santoro A; Mantovani A; Roncalli M; Malesci A
Lancet Oncol; 2009 Sep; 10(9):877-84. PubMed ID: 19656725
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
13. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.
Nagayoshi K; Ueki T; Nishioka Y; Manabe T; Mizuuchi Y; Hirahashi M; Oda Y; Tanaka M
Dis Colon Rectum; 2014 Apr; 57(4):467-74. PubMed ID: 24608303
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
[TBL] [Abstract][Full Text] [Related]
15. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.
Katz SC; Pillarisetty V; Bamboat ZM; Shia J; Hedvat C; Gonen M; Jarnagin W; Fong Y; Blumgart L; D'Angelica M; DeMatteo RP
Ann Surg Oncol; 2009 Sep; 16(9):2524-30. PubMed ID: 19568816
[TBL] [Abstract][Full Text] [Related]
16. Influence of subclinical tumor spreading on survival after curative surgery for colorectal cancer.
Steinert R; Hantschick M; Vieth M; Gastinger I; Kühnel F; Lippert H; Reymond MA
Arch Surg; 2008 Feb; 143(2):122-8. PubMed ID: 18283136
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of lymph node ratio in stage III colorectal cancer.
Wong KP; Poon JT; Fan JK; Law WL
Colorectal Dis; 2011 Oct; 13(10):1116-22. PubMed ID: 20874800
[TBL] [Abstract][Full Text] [Related]
18. Circular tumor growth: a prognostic factor in stage II colorectal carcinoma.
Jimi S; Hotokezaka M; Eto TA; Hidaka H; Maehara N; Chijiiwa K
Hepatogastroenterology; 2008; 55(84):926-9. PubMed ID: 18705299
[TBL] [Abstract][Full Text] [Related]
19. Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model.
Cianchi F; Messerini L; Comin CE; Boddi V; Perna F; Perigli G; Cortesini C
Dis Colon Rectum; 2007 Sep; 50(9):1332-41. PubMed ID: 17429709
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection.
Fujita S; Shimoda T; Yoshimura K; Yamamoto S; Akasu T; Moriya Y
J Surg Oncol; 2003 Nov; 84(3):127-31. PubMed ID: 14598355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
